Highlights & Chart Patterns of SUVEN LIFE SCIENCES LTD
Mild price rise. Caution keep a Tab on volume.
Candlestick pattern Bullish Harami formed with very weak volume. Possibly a bad signal
Doji Heikin Ashi Pattern formed
Long Term Support Line, Bottom Points : 59.35/03-Feb-23 00:00 59.85/01-Nov-22 00:00
Long Term Support Line, Bottom Points : 59.35/03-Feb-23 00:00 59.85/01-Nov-22 00:00
Long Term Descending Triangle , Top Points :69.8/29-Dec-22 00:00 73.4/13-Oct-22 00:00 , Bottom Points : 59.35/03-Feb-23 00:00 59.85/01-Nov-22 00:00
Nicely trending downwards
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide
Share Price History of SUVEN LIFE SCIENCES LTD
Date
Open
High
Low
Close
Volume
06-Feb-23
60.25
61.90
59.35
60.55
175 K
03-Feb-23
60.35
60.45
58.10
59.35
241 K
02-Feb-23
61.40
62.25
60.00
60.35
252 K
01-Feb-23
62.25
63.15
60.80
61.35
188 K
31-Jan-23
61.35
62.20
60.80
61.80
139 K
30-Jan-23
61.00
62.30
60.45
60.90
192 K
27-Jan-23
64.45
64.80
60.85
62.00
212 K
25-Jan-23
63.15
64.75
62.15
64.45
256 K
24-Jan-23
64.70
64.70
62.20
63.20
109 K
23-Jan-23
65.95
65.95
64.00
64.15
86744
About Suven Life Sciences Limited
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities (NCEs) in central nervous system therapies. Its product candidates include SUVN-502 for the treatment of Alzheimer's disease and neuropsychiatric symptoms; SUVN-G3031, a potent and selective histamine H3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and SUVN-911, a novel, potent, and selective a4�2 nicotinic acetylcholine receptor antagonist for the treatment of depressive disorders. The company is also developing SUVN-D4010, a potent, selective, and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders and schizophrenia; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.
TSR Tech Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is calculate from 5Mins Ticck to One Month Tick
TSR Growth analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access Growth Potential
TSR Value analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access its value
This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback
We are working on fundamental strength also. Please share your views to help shape up the requirement.
